Krsnaa Diagnostics: Board Strengthens Governance with Key Appointments
Krsnaa Diagnostics' Board of Directors, at its meeting on April 17, 2026, approved significant changes to its leadership and governance framework. Mr. Raju Venkatraman and Ms. Lilian Jessie Paul were appointed as Additional Independent Directors for two years. Mr. Chetan Desai was re-appointed as an Independent Director for five years. Mr. Chandra Prakash Singh was appointed as Interim CFO. Ms. Pallavi Bhatevara ceased to be a Whole-time Director, and Mr. Rajiva Ranjan Verma and Ms. Chhaya Palrecha ceased to be Independent Directors upon completion of their tenures. The Board also reconstituted its Audit, Nomination & Remuneration, CSR, Stakeholders Relationship, and Risk Management Committees, effective April 25, 2026. These changes aim to enhance the Board's experience and leadership.
Key Highlights
- Two new Independent Directors, Mr. Raju Venkatraman and Ms. Lilian Jessie Paul, appointed for two years.
- Mr. Chetan Desai re-appointed as Independent Director for a five-year term.
- Mr. Chandra Prakash Singh appointed as Interim Chief Financial Officer.
- Three directors, including a Whole-time Director and two Independent Directors, completed their tenures.
- Key Board Committees (Audit, NRC, CSR, Stakeholders, Risk) were reconstituted.
Price Impact
More from KRSNAA